{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        969, 
        975
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        976, 
        985
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        836, 
        859
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1495, 
        1515
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        890, 
        917
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        919, 
        923
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1476, 
        1480
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        559, 
        588
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1371, 
        1406
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1448, 
        1474
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        960, 
        968
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        987, 
        991
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        924, 
        930
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1481, 
        1487
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1016, 
        1048
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D0920291^CLIA|eMARCPlus|TN Cancer Registry|20170918000106||ORU^R01^ORU_R01|201709180001060001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-SK-002424^PathSys^44D0920291^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170906000000|||||||20170906000000|&Breast, Biopsy, not requiring microscopic margins, PQRS Breast IHC HER2|1790892743.^^^^^^MD^^CMS^D^^^NPI||||||20170908000000|||F||||||C50.912^Malignant neoplasm of unspecified site of left female breast^I10|1710939939&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nReceived in formalin labeled \", left breast 6-o'clock\" and consists of 4 tan-yellow fibrofatty core biopsies ranging in size from 0.6 cm to 2.0 cm in length and ranging from 0.2 cm to 0.3 cm in diameter. Entirely submitted in cassette 1A, 4/1.\n\n\nPath report.relevant Hx\n\nHistory - Left breast mass\n\n\nPath report.final diagnosis\n\nLeft breast, ultrasound-guided biopsy:   Invasive ductal carcinoma, high grade.   See comment.\n\n\nPath report.supplemental reports\n\nHormone Receptor report: Neoplastic cells are NEGATIVE for nuclear estrogen receptor. Neoplastic cells are NEGATIVE for nuclear progesterone receptor. Neoplastic cells show EQUIVOCAL (Score 2+) immunohistochemical evidence of HER-2 overexpression, HER-2 status will be confirmed by FISH.  ## End of auxiliary report ##\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.site of origin\n\nLeft breast mass\n\n\nPath report.comments\n\nComments - Invasive carcinoma involves four of four biopsy fragments and measures at least 2 cm in greatest dimension. Estimated grade 3/3 (tubule formation score 3, nuclear pleomorphism score 3, mitotic activity score 3). No definitive in situ component or lymphovascular invasion identified. Results discussed with Dr. Martz on 9/8/2017 at 8:48 AM. Breast receptor studies (ER/PR IHC and HER-2 IHC/FISH) will be performed and reported separately.\n\n\n"
}